MARKET
With MDMA on the brink of FDA approval, psychedelic medicine faces a critical moment
![](https://massachusettsdigitalnews.com/wp-content/uploads/2024/06/im-781397-780x470.jpeg)
A panel of independent advisers to the Food and Drug Administration is meeting Wednesday to discuss the agency’s potential approval of MDMA-assisted therapy for post-traumatic stress disorder, marking a pivotal moment for the booming field of psychedelic medicine.
Source link